Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT02174406
The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and DBT.
Looking for future studies?
Notify Me30 year and older
Female
Observational
New York, 10065, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
The detection rate of each imaging test is defined as the proportion of patients who are positive on that imaging test who truly have the disease compared to the total number of women screened. A positive imaging test is defined as a test with a recommendation for biopsy (BI-RADS 4 or 5).
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04761055
Breast Screening
New York, United States
View Trial DetailsNCT03846947
Breast Screening
Chapel Hill, North Carolina, United States
View Trial DetailsNCT01977599
Breast Screening
Hammersmith, London, United Kingdom
View Trial DetailsNCT03672331
Breast Screening
Brussels, Belgium
View Trial Details